Forward Citations = 1

Loading Chart...

8 inventors (with patents filed for the assignee):

Min Chul Park (3 out of 17 patents)

Sunghoon Kim (2 out of 134 patents)

Younha Kim (2 out of 2 patents)

4. Sunghwa Son (1 out of 1 patent)

5. Sumi Bae (1 out of 1 patent)

6. Jieun Park (1 out of 1 patent)

7. Su Jin Kang (1 out of 1 patent)

8. Yunsun Kim (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12663424 - ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOF (2026-06-23),

2. 11872263 - AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient (2024-01-16),

3. 11311601 - AIMP1 protein fragment and hair growth-promoting composition containing same as active ingredient (2022-04-26),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#192 in Gyeonggi-do

#2,793 in South Korea

Gyeonggi-do, South Korea

Curebio Therapeutics

Forward Citations = 1

8 inventors:

Min Chul Park (3 out of 17 patents)

Sunghoon Kim (2 out of 134 patents)

Younha Kim (2 out of 2 patents)

4. Sunghwa Son (1 out of 1 patent)

5. Sumi Bae (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curebio Therapeutics. Retrieved from https://idiyas.com/company/curebio-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]